Role of mast cell chymase in allergen-induced biphasic skin reaction

Biochemical Pharmacology

Volumn 64, Issue 7, 2002, Pages 1187-1193

  Tomimori, Yoshiaki ^a   Tsuruoka, Nobuo ^a   Fukami, Harukazu ^a   Saito, Kayo ^a   Horikawa, Chika ^a   Saito, Masayuki ^a   Muto, Tsuyoshi ^a   Sugiura, Namino ^a   Yamashiro, Kyoko ^a   Sumida, Motoo ^a   Kakutani, Saki ^a   Fukuda, Yoshiaki ^a  

^a SUNTORY LTD   (Japan)

Author keywords

Allergy; Atopic dermatitis; Biphasic reaction; Chymase; Leukocyte infiltration; Mast cell

Indexed keywords

3 (3 AMINOPHENYLSULFONYL) 7 CHLOROQUINAZORINE 2,4(1H,3H) DIONE; ALLERGEN; CHYMASE; ENZYME INHIBITOR; HISTAMINE; SUN C 8077; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCARIS; CHEMOTAXIS; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DERMATITIS; ENZYME INHIBITION; HISTOLOGY; HUMAN; HUMAN CELL; INFLAMMATORY CELL; LEUKOCYTE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN ALLERGY; SKIN INFLAMMATION; SKIN MANIFESTATION;

ANIMALS; CHEMOTAXIS; CHYMASES; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; EDEMA; HISTAMINE ANTAGONISTS; HUMANS; HYPERSENSITIVITY; LEUKOCYTES; MAST CELLS; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; SERINE ENDOPEPTIDASES;

EID: 0036774338     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)01265-0     Document Type: Article

References (31)

1. Ray M.C., Tharp M.D., Sullivan T.J., Tigelaar R.E. Contact hypersensitivity reactions to dinitrofluorobenzene mediated by monoclonal IgE anti-DNP antibodies. J. Immunol. 131:1983;1096-1102.
2. Barata L.T., Ying S., Meng Q., Barkans J., Rajakulasingam K., Durham S.R., Kay A.B. IL-4- and IL-5-positive T lymphocytes, eosinophils, and mast cells in allergen-induced late-phase cutaneous reactions in atopic subjects. J. Allergy Clin. Immunol. 101:1998;222-230.
3. Nagai H., Sakurai T., Inagaki N., Mori H. An immunopharmacological study of the biphasic allergic skin reaction in mice. Biol. Pharm. Bull. 18:1995;239-245.
4. Inagaki N., Sakurai T., Abe T., Musoh K., Kawasaki H., Tsunematsu M., Nagai H. Characterization of antihistamines using biphasic cutaneous reaction in BALB/c mice. Life Sci. 63:1998;PL145-PL150.
5. + T lymphocytes and interleukin-5 in antigen-induced eosinophil recruitment into the site of cutaneous late-phase reaction in mice. J. Leukoc. Biol. 52:1992;572-578.
6. Kay A.B., Barata L., Meng Q., Durham S.R., Ying S. Eosinophils and eosinophil-associated cytokines in allergic inflammation. Int. Arch. Allergy Immunol. 113:1997;196-199.
7. Welle M. Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. J. Leukoc. Biol. 61:1997;233-245.
8. Fukami H., Okunishi H., Miyazaki M. Chymase: its pathophysiological roles and inhibitors. Curr. Pharm. Des. 4:1998;439-453.
9. He S., Walls A.F. The induction of a prolonged increase in microvascular permeability by human mast cell chymase. Eur. J. Pharmacol. 352:1998;91-98.
10. He S., Walls A.F. Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo. Br. J. Pharmacol. 125:1998;1491-1500.
11. Mizutani H., Schechter N., Lazarus G., Black R.A., Kupper T.S. Rapid and specific conversion of precursor interleukin 1β (IL-1β) to an active IL-1 species by human mast cell chymase. J. Exp. Med. 174:1991;821-825.
12. Longley B.J., Tyrrell L., Ma Y., Williams D.A., Halaban R., Langley K., Lu H.S., Schechter N.M. Chymase cleavage of stem cell factor yields a bioactive, soluble product. Proc. Natl. Acad. Sci. U.S.A. 94:1997;9017-9021.
13. ν mice and their increase by bone marrow transplantation. Blood. 52:1978;447-452.
14. Yamashiro K., Tsuruoka N., Kodama S., Tsujimoto M., Yamamura Y., Tanaka T., Nakazato H., Yamaguchi N. Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain. Biochim. Biophys. Acta. 1350:1997;11-14.
15. Urata H., Kinoshita A., Perez D.M., Misono K.S., Bumpus F.M., Graham R.M., Husain A. Cloning of the gene and cDNA for human heart chymase. J. Biol. Chem. 266:1991;17173-17179.
16. Tsuruoka N., Yamashiro K., Tsujimoto M. Purification of soluble murine interleukin 5 (IL-5) receptor α expressed in Chinese hamster ovary cells and its action as an IL-5 antagonist. Arch. Biochem. Biophys. 307:1993;133-137.
17. Sengoku T., Morita K., Sato S., Sakuma S., Ogawa T., Hiroi J., Fujii T., Goto T. Effects of tacrolimus ointment on type I (immediate and late) and IV (delayed) cutaneous allergic reactions in mice. Nippon Yakurigaku Zasshi. 112:1998;221-232.
18. Fukami H., Imajo S., Ito A., Kakutani S., Shibata H., Sumida M., Tanaka T., Niwata S., Saitoh M., Kiso Y., Miyazaki M., Okunishi H., Urata H., Arakawa K. Substituted 3-phenylsulfonylquinazoline-2,4-dione derivatives as novel nonpeptide inhibitors of human heart chymase. Drug Des. Discov. 17:2000;69-84.
19. Nishikori Y., Kakizoe E., Kobayashi Y., Shimoura K., Okunishi H., Dekio S. Skin mast cell promotion of matrix remodeling in burn wound healing in mice: relevance of chymase. Arch. Dermatol. Res. 290:1998;553-560.
20. Schick B., Austen K.F. Rat serosal mast cell degranulation mediated by chymase, an endogenous secretory granule protease: active site-dependent initiation at 1°C. J. Immunol. 136:1986;3812-3818.
21. Tani K., Ogushi F., Kido H., Kawano T., Kunori Y., Kamimura T., Cui P., Sone S. Chymase is a potent chemoattractant for human monocytes and neutrophils. J. Leukoc. Biol. 67:2000;585-589.
22. Katayama I., Tanei R., Yokozeki H., Nishioka K., Dohi Y. Induction of eczematous skin reaction in experimentally induced hyperplastic skin of Balb/C mice by monoclonal anti-DNP IgE antibody: possible implications for skin lesion formation in atopic dermatitis. Int. Arch. Allergy Appl. Immunol. 93:1990;148-154.
23. Yamatodani A., Maeyama K., Watanabe T., Wada H., Kitamura Y. Tissue distribution of histamine in a mutant mouse deficient in mast cells: clear evidence for the presence of non-mast-cell histamine. Biochem. Pharmacol. 31:1982;305-309.
24. Woodbury RG, Le Trong H, Cole K, Neurath H, Miller HR. Rat mast cell proteases. In: Galli S, Austen KF, editors. Mast Cell and Basophil Differentiation and Function in Health and Disease. New York: Raven Press, 1989. p. 71-9.
25. Scudamore C.L., Thornton E.M., McMillan L., Newlands G.F., Miller H.R. Release of the mucosal mast cell granule chymase, rat mast cell protease-II, during anaphylaxis is associated with the rapid development of paracellular permeability to macromolecules in rat jejunum. J. Exp. Med. 182:1995;1871-1881.
26. Scudamore C.L., Jepson M.A., Hirst B.H., Miller H.R. The rat mucosal mast cell chymase, RMCP-II, alters epithelial cell monolayer permeability in association with altered distribution of the tight junction proteins ZO-1 and occludin. Eur. J. Cell. Biol. 75:1998;321-330.
27. Sambrano G.R., Huang W., Faruqi T., Mahrus S., Craik C., Coughlin S.R. Cathepsin G activates protease-activated receptor-4 in human platelets. J. Biol. Chem. 275:2000;6819-6823.
28. Tannenbaum S., Oertel H., Henderson W., Kaliner M. The biologic activity of mast cell granules. I. Elicitation of inflammatory responses in rat skin. J. Immunol. 125:1980;325-335.
29. Matsuda H., Kawakita K., Kiso Y., Nakano T., Kitamura Y. Substance P induces granulocyte infiltration through degranulation of mast cells. J. Immunol. 142:1989;927-931.
30. Inagaki N., Goto S., Nagai H., Koda A. Homologous passive cutaneous anaphylaxis in various strains of mice. Int. Arch. Allergy Appl. Immunol. 81:1986;58-62.
31. Nagai H., Ueda Y., Ochi T., Hirano Y., Tanaka H., Inagaki N., Kawada K. Different role of IL-4 in the onset of hapten-induced contact hypersensitivity in BALB/c and C57BL/6 mice. Br. J. Pharmacol. 29:2000;299-306.